Alexandria Real Estate Equities
ARE
#2013
Rank
C$13.79 B
Marketcap
C$80.80
Share price
1.62%
Change (1 day)
-43.42%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) Fails to deliver data

Key failure to deliver metrics for Alexandria Real Estate Equities :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alexandria Real Estate Equities (ARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alexandria Real Estate Equities (ARE) - since 2013

Volume in USD (price x number of shares), data since 2013

Alexandria Real Estate Equities (ARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$38.06 M-37.06%
2024C$60.47 M46.83%
2023C$41.18 M-64.08%
2022C$0.11 B22.18%
2021C$93.85 M-16.64%
2020C$0.11 B38.94%
2019C$81.03 M-10.89%
2018C$90.94 M-43.57%
2017C$0.16 B192.01%
2016C$55.19 M125.93%
2015C$24.42 M11.4%
2014C$21.92 M875.57%
2013C$2.24 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
C$55.69 MC$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$30.94 MC$0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$0.22 BC$0.41 B๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$2.54 MC$15.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$29.11 MC$80.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$78.98 MC$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$13.15 MC$42.8 M๐Ÿ‡บ๐Ÿ‡ธ USA